Protagenic Therapeutics, Inc. (PTIX)
PTIX Stock Price Chart
Explore Protagenic Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze PTIX price movements and trends.
PTIX Company Profile
Discover essential business fundamentals and corporate details for Protagenic Therapeutics, Inc. (PTIX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Apr 2021
Employees
1.00
Website
https://www.protagenic.comCEO
Garo H. Armen
Description
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by stress. Foremost among its investigational products is PT00114, a laboratory-synthesized version of the teneurin carboxy-terminal associated peptide. This compound functions by emulating an innate brain signaling peptide, known for its ability to temper exaggerated stress reactions. The company's headquarters are located in New York, New York.
PTIX Financial Timeline
Browse a chronological timeline of Protagenic Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
PTIX Stock Performance
Access detailed PTIX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
